Jpmorgan Chase & Co »

Viridian Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Viridian Therapeutics shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Viridian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viridian Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viridian Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $106k 100k 1.06

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Viridian Therapeutics

Context Capital Management
Citadel Advisors
Polar Securities
Ubs Global Asset Management Americas
D. E. Shaw & Co
Linden Advisors
DeepCurrents Investment Group
Nuveen
Jane Street
Tenor Capital Management
Silverback Asset Management
BlackRock
Nicholas Investments Partners
Capstone Investment Advisors
CSS

View all funds holding Viridian Therapeutics